HOME >> BIOLOGY >> NEWS
Common asthma drug saves patients money, trips to hospital

s. Patient data was used only if the patient hadn't taken any of the three drugs for the first nine months, followed by nine months of using one of the prescribed medications.

"Our findings are based on real-world data," Pathak said. "We analyzed the data after doctors had already prescribed one of the three drugs to their patients."

Patient data was split into three groups, based on the drug prescribed: 284 patients used fluticasone propionate in either 0.044 or 0.110 milligram doses; 302 used montelukast in 5 and 10 milligram doses; and 195 used zafirlukast in 20 milligram doses. The latter two drugs were taken in tablet form.

The average total cost of asthma care for a patient using fluticasone propionate during the nine-month period was $528. The cost was nearly double for montelukast users ($967), and it nearly tripled for zafirlukast users ($1,359). Total cost included filling prescriptions, trips to doctors' offices and emergency rooms, hospitalizations and the need for additional medication to control asthma symptoms.

The use of fluticasone propionate was also linked to fewer hospitalizations and less of a need for additional medication to control asthma symptoms - the data showed that patients could get by longer on a regimen of fluticasone propionate alone.

"An inhaled corticosteroid, which fluticasone propionate is, should be considered the first line of therapy in patients with symptoms of
'"/>

Contact: Dev Pathak
Pathak.1@osu.edu
614-688-3956
Ohio State University
10-Apr-2002


Page: 1 2 3 4

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common airborne substance makes asthmatics more sensitive to house dust mites: study
8. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
9. Common nutrients fed to pregnant mice altered their offsprings coat color
10. Common treatment for depression is safe and effective for Alzheimers patients
11. Common gene variant increases risk of atherosclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/26/2017)...  Acuity Market Intelligence today released the 2017 ...  Acuity characterizes 2017 as a "breakout" year for ... a new understanding of the potential benefits these ... identity are often perceived as threats to privacy ... of Acuity Market intelligence. "However, taken together these ...
(Date:1/24/2017)... 24, 2017  It sounds simple and harmless—an ... monitors vital signs and alerts parents on their ... saturation level drops. But pediatric experts argue that ... with no evidence of medical benefits, especially to ... aggressively to parents of healthy babies, promising peace ...
(Date:1/19/2017)... 19, 2017 According to a new report published by ... - 2022," the global biometric sensor market is expected to garner $1.5 billion ... 2015, Asia-Pacific dominated the global market and contributed over ... Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Calif. and GREENWICH, Conn. ... a private investment firm focused on venture growth ... the promotion of Josh Richardson , M.D. ... on investments in biotechnology companies.  He is a ... played important roles in Longitude,s investments in Aimmune ...
(Date:2/16/2017)... -- Research and Markets has announced the ... report to their offering. ... The study scope ... plasmids, chassis organisms, synthetic cells, production systems), enabling technologies ... and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, ...
(Date:2/16/2017)... BEACH, Florida , February 16, 2017 /PRNewswire/ ... improving with the infusion of innovative telemedicine application, ... monitoring services that are experiencing a boom worldwide. ... with the advancement of technologies, services and new ... Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
Breaking Biology Technology:
Cached News: